Does Vascular Collapse Occur After Treatment of Hepatocellular Cancer With Stereotactic Body Radiation Therapy?

There is debate about why stereotactic body radiation therapy (SBRT) produces superior control of hepatocellular cancer (HCC) compared to fractionated treatment. Both preclinical and clinical evidence has been presented to support a "classic" biological explanation: the greater BED of SBRT produces more DNA damage and tumor cell kill. More recently, preclinical evidence has supported the concept of a "new biology", particularly radiation-induced vascular collapse, which increases hypoxia and free radical activation. This is hypothesized to cause much greater tumor cell death than was produced by the initial radiation-induced DNA damage to the tumor. We decided to investigate if vascular collapse occurs after standard SBRT for patients with HCC. Eight patients with 10 lesions underwent dynamic contrast enhanced MRI at the time of simulation and either 48 or 96 hours after the first fraction. Only three of 10 tumors showed a decrease in blood flow. These findings suggest that vascular collapse does not typically occur after SBRT for HCC.

Prostate Radiotherapy With Adjuvant Androgen Deprivation Therapy (ADT) Improves Metastasis-Free Survival Compared to Neoadjuvant ADT: An Individual Patient Meta-Analysis.

PURPOSE: There remains a lack of clarity regarding the influence of sequencing of androgen deprivation therapy (ADT) and radiotherapy (RT) on outcomes in prostate cancer (PCa). Herein, we evaluate the optimal sequencing of ADT with prostate-directed RT in localized PCa. METHODS: MEDLINE (1966-2018), Embase (1982-2018), ClinicalTrials.gov, and conference proceedings (1990-2018) were searched to identify randomized trials evaluating the sequencing, but not duration, of ADT with RT. Two randomized phase III trials were identified, and individual patient data were obtained: Ottawa 0101 and NRG Oncology's Radiation Therapy Oncology Group 9413. Ottawa 0101 randomly assigned patients to neoadjuvant or concurrent versus concurrent or adjuvant short-term ADT. Radiation Therapy Oncology Group 9413, a 2 × 2 factorial trial, included a random assignment of neoadjuvant or concurrent versus adjuvant short-term ADT. The neoadjuvant or concurrent ADT arms of both trials were combined into the neoadjuvant group, and the arms receiving adjuvant ADT were combined into the adjuvant group. The primary end point of this meta-analysis was progression-free survival (PFS). RESULTS: The median follow-up was 14.9 years. Overall, 1,065 patients were included (531 neoadjuvant and 534 adjuvant). PFS was significantly improved in the adjuvant group (15-year PFS, 29% v 36%, hazard ratio [HR], 1.25 [95% CI, 1.07 to 1.47], P = .01). Biochemical failure (subdistribution HR [sHR], 1.37 [95% CI, 1.12 to 1.68], P = .002), distant metastasis (sHR, 1.40 [95% CI, 1.00 to 1.95], P = .04), and metastasis-free survival (HR, 1.17 [95% CI, 1.00 to 1.37], P = .050) were all significantly improved in the adjuvant group. There were no differences in late grade ≥ 3 gastrointestinal (2% v 3%, P = .33) or genitourinary toxicity (5% v 5%, P = .76) between groups. CONCLUSION: The sequencing of ADT with prostate-directed RT has significant association with long-term PFS and MFS in localized PCa. Our findings favor use of an adjuvant over a neoadjuvant approach, without any increase in long-term toxicity.

Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.

PURPOSE: Doses actually delivered to the parotid glands during radiation therapy often exceed planned doses. We hypothesized that the delivered doses correlate better with parotid salivary output than the planned doses, used in all previous studies, and that determining these correlations will help make decisions regarding adaptive radiation therapy (ART) aimed at reducing the delivered doses. METHODS AND MATERIALS: In this prospective study, oropharyngeal cancer patients treated definitively with chemoirradiation underwent daily cone-beam computed tomography (CBCT) with clinical setup alignment based on the C2 posterior edge. Parotid glands in the CBCTs were aligned by deformable registration to calculate cumulative delivered doses. Stimulated salivary flow rates were measured separately from each parotid gland pretherapy and periodically posttherapy. RESULTS: Thirty-six parotid glands of 18 patients were analyzed. Average mean planned doses was 32 Gy, and differences from planned to delivered mean gland doses were -4.9 to +8.4 Gy, median difference +2.2 Gy in glands in which delivered doses increased relative to planned. Both planned and delivered mean doses were significantly correlated with posttreatment salivary outputs at almost all posttherapy time points, without statistically significant differences in the correlations. Large dispersions (on average, SD 3.6 Gy) characterized the dose-effect relationships for both. The differences between the cumulative delivered doses and planned doses were evident at first fraction (r=.92, P<.0001) because of complex setup deviations (eg, rotations and neck articulations), uncorrected by the translational clinical alignments. CONCLUSIONS: After daily translational setup corrections, differences between planned and delivered doses in most glands were small relative to the SDs of the dose-saliva data, suggesting that ART is not likely to gain measurable salivary output improvement in most cases. These differences were observed at first treatment, indicating potential benefit for more complex setup corrections or adaptive interventions in the minority of patients with large deviations detected early by CBCT.

Quantitative CT of lung nodules: dependence of calibration on patient body size, anatomic region, and calibration nodule size for single- and dual-energy techniques.

Calcium concentration may be a useful feature for distinguishing benign from malignant lung nodules in computer-aided diagnosis. The calcium concentration can be estimated from the measured CT number of the nodule and a CT number vs calcium concentration calibration line that is derived from CT scans of two or more calcium reference standards. To account for CT number nonuniformity in the reconstruction field, such calibration lines may be obtained at multiple locations within lung regions in an anthropomorphic phantom. The authors performed a study to investigate the effects of patient body size, anatomic region, and calibration nodule size on the derived calibration lines at ten lung region positions using both single energy (SE) and dual energy (DE) CT techniques. Simulated spherical lung nodules of two concentrations (50 and 100 mg/cc CaCO3) were employed. Nodules of three different diameters (4.8, 9.5, and 16 mm) were scanned in a simulated thorax section representing the middle of the chest with large lung regions. The 4.8 and 9.5 mm nodules were also scanned in a section representing the upper chest with smaller lung regions. Fat rings were added to the peripheries of the phantoms to simulate larger patients. Scans were acquired on a GE-VCT scanner at 80, 120, and 140 kVp and were repeated three times for each condition. The average absolute CT number separations between the calibration lines were computed. In addition, under- or overestimates were determined when the calibration lines for one condition (e.g., small patient) were used to estimate the CaCO3 concentrations of nodules for a different condition (e.g., large patient). The authors demonstrated that, in general, DE is a more accurate method for estimating the calcium contents of lung nodules. The DE calibration lines within the lung field were less affected by patient body size, calibration nodule size, and nodule position than the SE calibration lines. Under- or overestimates in CaCO3 concentrations of nodules were also in general smaller in quantity with DE than with SE. However, because the slopes of the calibration lines for DE were about one-half the slopes for SE, the relative improvement in the concentration estimates for DE as compared to SE was about one-half the relative improvement in the separation between the calibration lines. Results in the middle of the chest thorax section with large lungs were nearly completely consistent with the above generalization. On the other hand, results in the upper-chest thorax section with smaller lungs and greater amounts of muscle and bone were mixed. A repeat of the entire study in the upper thorax section yielded similar mixed results. Most of the inconsistencies occurred for the 4.8 mm nodules and may be attributed to errors caused by beam hardening, volume averaging, and insufficient sampling. Targeted, higher resolution reconstructions of the smaller nodules, application of high atomic number filters to the high energy x-ray beam for improved spectral separation, and other future developments in DECT may alleviate these problems and further substantiate the superior accuracy of DECT in quantifying the calcium concentrations of lung nodules.